FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma

Figure 6

(a, b) The correlations between FCGBP and immune checkpoints in OSCC samples.

(a)

(b)